Calmday

Quick links to important sections

Calmday

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calmday

Quick Facts

Property Description
Active ingredient Nordazepam (Desmethyldiazepam)
Form Tablet or capsule (Oral)
Pharmacological class Benzodiazepine, Anxiolytic
General purpose Provides a generalized calming effect
Origin Synthetic

Calmday: Classification and the Role of Nordazepam

Calmday, representing the pharmaceutical product containing the active ingredient Nordazepam, is a synthetic, prescription-only medicine. It belongs to the benzodiazepine pharmacological class, which is clinically recognized for its ability to produce a controlled calming and anti-anxiety effect. Nordazepam, also identified as Desmethyldiazepam, is the single therapeutic agent present in the formulation.

Nordazepam is functionally classified as a long-acting benzodiazepine. It is distinguished from other agents in its class because it often acts as an active, persistent metabolite of compounds like diazepam. The extended activity contributes to its sustained duration of presence in the body. The fundamental purpose of this classification is to signify the drug's general utility in moderating high activity in the central nervous system, thereby providing consistent, prolonged relief from states of mental tension.

Composition, Form, and General Purpose

The medicine is designed as a single-ingredient product for oral administration, typically supplied as a tablet or capsule. These standard dosage preparations combine the active compound, Nordazepam, with essential pharmaceutical excipients—inert components necessary to create a measurable and stable dose.

The core function of the medicine involves enhancing the brain’s natural inhibitory pathways. The drug is classified as a Central Nervous System (CNS) depressant, which translates into the general benefit of fostering a sense of calmness and relaxation. This action is frequently used to provide relief in situations characterized by heightened anxiety or restlessness.

What side effects are possible with Calmday?

Possible side effects and safety information

The safety profile of Calmday (Nordazepam) is characterized by its classification as a long-acting Central Nervous System (CNS) depressant, with documented risks detailed in official regulatory sources. Adverse reactions are grouped by frequency and body system involved.


Documented Adverse Reactions and Frequency

Adverse effects most frequently reported (classified as Common in regulatory documents) are direct consequences of its CNS depressant action. These include drowsiness (somnolence), fatigue, headache, dizziness, and impaired coordination (ataxia). These reactions are often noted to occur most frequently at the start of treatment and may subside with continued use.

Other effects are listed in official documents under Nervous System and Psychiatric Disorders, such as confusion, memory impairment (anterograde amnesia), and muscle weakness (hypotonia). Regulatory texts also note the potential for paradoxical reactions, which include agitation, irritability, and aggression.


Serious Safety Considerations

The official safety profile highlights critical risks associated with the medicine's class. The label contains warnings regarding the risk of physical dependence and tolerance, which can develop even after short-term therapeutic use. Abrupt discontinuation can lead to potentially life-threatening acute withdrawal reactions, including seizures.

Additionally, concomitant use with opioids or other CNS depressants significantly increases the risk of severe outcomes, including profound sedation and respiratory depression.


Population-Specific Safety Notes

The label defines specific considerations for vulnerable groups. Older adults (geriatric patients) are explicitly noted to have an increased sensitivity to CNS depressant effects, resulting in a higher risk of falls and injuries due to impaired coordination. The drug is contraindicated in conditions such as severe hepatic insufficiency and severe respiratory insufficiency, based on regulatory constraints documented in the prescribing information.

Overdose and Emergency Response

Overdose with the active ingredient Nordazepam, a central nervous system depressant, primarily results in manifestations of acute CNS depression. Documented signs include extreme somnolence, confusion, ataxia (loss of coordination), dysarthria (slurred speech), and diminished reflexes.

Severe Outcomes and Emergency Action

Regulatory authorities note that overdose may progress to coma, hypotension (low blood pressure), and potentially life-threatening respiratory depression. The risk of these severe outcomes is significantly amplified if the medication is taken alongside other CNS depressants, such as alcohol or opioids, as documented in official warnings.

Immediate medical attention is required upon any suspected overdose. Government guidance mandates that individuals contact emergency services immediately if severe or life-threatening symptoms, such as significant breathing difficulty or deep coma, are present.

Management and Monitoring

The official management strategy focuses on symptomatic and supportive treatment. This includes maintaining a patent airway and continuously monitoring vital signs. A specific receptor antagonist is available; however, its administration is noted by regulators to require caution and is reserved for specific clinical circumstances due to associated risks. Regulatory documents also specify that hospital monitoring is required to observe for delayed or evolving effects, particularly in the elderly and those with hepatic impairment, who are considered at higher risk for severe outcomes.

Therapeutic Uses of Calmday

What Calmday Treats: Main Uses and Benefits

Calmday is generally used in situations involving certain distressing symptoms, applied across domains where additional symptomatic support is needed for acute or episodic manifestations of anxiety and agitation. This class of medications is used to relieve anxiety and control agitation. This use is considered relevant in contexts marked by increased discomfort or tension.

The medication is applied in addressing symptom clusters that may become intense or disruptive, including pronounced worry, physical tension and restlessness, and sleep disturbed by agitation.

When symptoms intensify and supportive relief is needed, Calmday contributes to easing the overall symptom load and supports general well-being during symptomatic phases. This supportive relief may assist with helping patients cope more steadily with symptom fluctuations.

Key Focus: Supportive Relief for Physical Tension

Calmday may assist with managing symptoms related to heightened physiological activity, such as muscle stiffness and inability to sit still. This supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information for a related anxiolytic

Eligibility and Restrictions for Use

Who Can and Cannot Use Calmday?

The population eligibility for Calmday (Nordazepam), a long-acting benzodiazepine, is strictly defined by regulatory documents, which list specific patient groups for whom the medicine is contraindicated or subject to major restrictions.

Contraindicated Populations

Use of Calmday is contraindicated (must not be used) in patients with specific acute or chronic conditions, including:

  • Hypersensitivity to Nordazepam or the benzodiazepine class.
  • Myasthenia Gravis and Severe Respiratory Insufficiency.
  • Severe Hepatic Insufficiency or Severe Liver Disease.
  • Sleep Apnoea Syndrome.
  • Acute Intoxication with alcohol or other central nervous system depressants.

Age and Physiological Restrictions

Population Group Regulatory Status
Infants (< 6 months) Safety and effectiveness have not been established.
Children & Adolescents (< 18 yrs) Generally not recommended or not indicated for the labeled use.
Older Adults/Elderly Patients Not recommended or requires special caution due to slower drug metabolism and increased sensitivity to effects.
Pregnancy Not recommended (especially in the first and third trimesters).
Lactation/Breastfeeding Contraindicated as the substance is excreted in breast milk.

Additionally, the medicine is contraindicated in patients with severe depression or psychosis, and its use is restricted with extreme caution in those with a history of alcohol or drug dependence, as stated in official labeling.

What should I know about interactions with other medicines?

The official interaction profile is structured by documented patterns of pharmacodynamic enhancement and pharmacokinetic modification. The most stringent restrictions apply to pharmacodynamic interactions, where co-administration results in an additive central nervous system (CNS) depressant effect.

The combination with Opioids is associated with a formal Boxed Warning due to the documented risk of profound sedation, respiratory depression, coma, and death. Similarly, Alcohol (Ethanol) must be avoided as it enhances CNS inhibition and increases the risk of fatal overdose. Other CNS depressants, including antipsychotics, sedating antihistamines, and certain other anxiolytics, also enhance the central depressive effect.

Specific interactions are documented for metabolic pathways. Compounds that inhibit CYP enzymes (e.g., Cimetidine, Omeprazole) reduce the drug's metabolic clearance, resulting in officially recognized increased plasma concentrations. Conversely, CYP enzyme inducers (e.g., Rifampicin) are documented to increase metabolism, leading to decreased drug concentrations and reduced systemic exposure. The co-administration of Sodium Valproate may also increase serum levels by inhibiting glucuronidation.

In special populations, such as patients with severe hepatic insufficiency, co-administration of CNS depressants carries the official risk of precipitating encephalopathy due to impaired clearance. The concurrent use of antacids is also noted as potentially delaying the absorption of the drug.

Mechanism of Action

How Calmday Works: Mechanism of Action

Calmday acts as a Positive Allosteric Modulator of the Gamma-aminobutyric acid type A (GABAA) receptor complex within the Central Nervous System (CNS). This receptor is the primary target for inhibitory signaling. Calmday binds to an allosteric site separate from the GABA binding site, which modifies the receptor's conformation. This molecular interaction enhances the ability of the native neurotransmitter GABA to open the receptor's integral ion channel.

The consequent increase in channel opening frequency and/or duration promotes the heightened flow of negatively charged chloride ions into the post-synaptic neuron. This influx of ions causes neuronal hyperpolarization, making the nerve cell less electrically excitable. The resulting widespread reduction in neuronal excitability across the CNS contributes to observable systemic physiological changes, including a decrease in resting muscle tone and a generalized dampening of CNS arousal.

Dosage and Administration Information

How to Use Calmday

The administration of Calmday (Nordazepam) is governed by instructions for its route, dose, frequency, and duration, consistent with standards for this pharmacological class. The medicine is a single-ingredient product available for oral administration as a tablet or capsule.


Official Administration Guidelines

Property Administration Instruction
Route and Form Oral administration only; tablets or capsules must be swallowed whole and should not be crushed.
Standard Adult Dose Starting doses are typically 2 mg, administered in divided doses (2 to 4 times daily).
Maintenance Range Doses are generally maintained between 2 mg to 10 mg, taken 2 to 4 times daily, with a recommended maximum of 40 mg total per day.
Context The medicine may be taken with or without food.
Duration Limit Treatment should be limited to the shortest possible duration, typically not exceeding 4 weeks, which includes the mandatory tapering period.

Population-Specific Use

Specific dose modifications are required for certain populations to ensure proper use. Older adults (geriatric patients) must be initiated on a significantly lower dose, usually 2 mg to 2.5 mg, 1 to 2 times daily, due to increased sensitivity to the effects of the compound. Patients with documented hepatic or renal impairment may also require a reduced dosage because the body's ability to process and eliminate the long-acting medicine may be impaired, leading to accumulation.

Procedural Protocol

Proper use of Calmday requires adherence to two key procedural constraints: using the lowest effective dose for the shortest time possible, and implementing a gradual dose reduction (taper) when discontinuing use. This tapering process is mandatory to minimize systemic effects related to abrupt cessation.

Recent Clinical Evidence

Research evidence / Overview of Studies for Calmday (Nordazepam)

Evidence for Symptomatic Relief of Acute Anxiety and Tension

Research related to Calmday, or its active ingredient Nordazepam, and its parent compounds has been used in research exploring how symptoms change over time in individuals experiencing high levels of anxiety or tension. The research generally consists of short-term, randomized controlled trials (RCTs) and meta-analyses that look at the broader benzodiazepine class. Studies examined outcomes related to systemic or functional imbalance, such as patient-reported outcomes describing perceived discomfort and the monitoring of measured anxiety scores used to measure symptom intensity or variability. Populations included in these studies were mainly adults presenting with conditions characterized by fluctuating or episodic manifestations of anxiety.

The findings describe patterns observed in the studies where researchers focused on the monitoring of measured anxiety scores during the short observation periods. Research has explored the monitoring of signs of physical tension in the immediate hours following administration. Nordazepam is classified as a long-acting compound, and the research contributes to the broader evidence landscape by providing insight into short-term changes that was observed in some studies lasting up to a few weeks.

Research indicates the following uncertainties: Evidence for Nordazepam is often derived from trials of related drugs that convert into it. As such, modern, large-scale RCTs focusing solely on Nordazepam versus a non-active control are less frequent. Limited information for long-term outcomes is available, as the follow-up durations were limited in most key studies.


Evidence for Symptomatic Management of Sleep Disturbance

Calmday was studied for its impact on sleep, specifically in individuals who have conditions associated with acute or disruptive episodes of sleep difficulty, often related to agitation. Systematic reviews and specific clinical trials research examined how this class of medicine affects sleep patterns in adults. The studies monitored outcomes reflecting daily functioning or activity level, primarily focusing on objective sleep metrics, such as the monitoring of the time needed to fall asleep and the monitoring of total sleep duration. Patient-reported outcomes describing perceived discomfort with sleep were also part of the research focus.

What Remains Uncertain About the Research Base

A key limitation is that comparative evidence is lacking for Nordazepam alone in many newer clinical settings, with much of the data inherited from studies of drugs like diazepam, which metabolize into Nordazepam. Furthermore, the evidence quality varies across studies, particularly in older trials, and the follow-up durations were limited. The lack of long-term data indicates that long-term effects are not fully established, and evidence contributes to understanding symptom patterns primarily during acute, short-term use.

Key Studies & References

  1. Meta-analysis of benzodiazepine use in the treatment of insomnia
  2. Benzodiazepine and Z-Drug Safety Guideline (Kaiser Permanente Washington) - Guidance on short-term use and high-risk populations
  3. Long-term use of benzodiazepines in chronic insomnia: a European perspective
  4. Summary of Product Characteristics (SPC) - Diazepam (Used for metabolism/parent drug context)

Frequently Asked Questions (FAQ)

Common questions about Calmday (FAQ)


Q: How quickly does Calmday start to work after I take the first dose?

A: Calmday is classified as a long-acting compound, and its onset of action may be delayed compared to faster-acting medicines in the same class. Official information for related compounds indicates that the time it takes to reach peak levels in the bloodstream may be over an hour. Documentation for related compounds notes that the co-administration of food may be associated with a delay in the onset of action.


Q: How long does the effect of one dose of Calmday typically last?

A: The active ingredient in Calmday is officially classified as a long-acting compound. Regulatory documents note that it has a prolonged terminal elimination half-life, which can extend up to 100 hours. This prolonged half-life reflects its sustained duration of presence in the body.


Q: Does Calmday have a reputation for being 'addictive' or causing dependence?

A: Official labeling includes regulatory warnings noting that the medicine is associated with risks of physical dependence and tolerance, even when used for short periods at prescribed doses. Regulatory agencies require these warnings to address risks related to physical dependence.


Q: What is the recommended approach for stopping Calmday when it's no longer needed?

A: The official requirement for discontinuation is a gradual dose reduction process. To minimize the risk of acute withdrawal reactions, which include seizures, the drug should not be stopped abruptly.


Q: Can I take Calmday if I am pregnant or breastfeeding?

A: The official documentation states that use during pregnancy is generally not recommended, especially during the first and third trimesters. The drug is contraindicated (officially restricted) during breastfeeding because the substance is known to be excreted in breast milk.


Q: Is it necessary to take Calmday with food?

A: Official administration guidelines state that the medicine may be taken with or without food. Official information notes that the concurrent use of antacids may delay the absorption of the drug.


Q: What is the maximum amount of time Calmday is typically used for?

A: Regulatory guidelines state that treatment duration should be limited to the shortest possible time, typically not exceeding 4 weeks, which includes any necessary tapering period. This limitation is noted due to risks associated with dependence and tolerance.


Q: Is there a generic version of Calmday available?

A: The active compound is Nordazepam, which is an existing chemical substance. Official policies on drug naming and classification indicate that this substance may be available from various manufacturers as a generic or authorized generic version, depending on local regulatory approvals.


Q: What happens if a dose of Calmday is accidentally missed?

A: General patient guidelines from official sources address missed doses by stating that the dose may be taken when remembered, unless it is near the time for the next scheduled administration. Patients are typically advised to avoid taking a double dose to compensate for a forgotten one.


Q: Are there any known long-term side effects associated with Calmday use?

A: Official documents caution that long-term use is associated with a risk of developing tolerance and physical dependence. Long-term use is also associated with the potential for cognitive impairment or sleep disturbance that may persist after the medicine is discontinued. Research on follow-up periods exceeding a few weeks remains limited.


Q: Is it safe to drink coffee or caffeine while taking Calmday?

A: Official safety documents do not contain specific warnings regarding caffeine consumption. However, the medicine is classified as a Central Nervous System (CNS) depressant. Patients are generally advised to be aware of other substances that affect the CNS, as their combined effects may be unpredictable.


Q: If I am taking a herbal supplement, should I be concerned about interactions with Calmday?

A: Official health guidance generally advises caution regarding the combination of this medicine with herbal remedies, particularly those intended for anxiety or sleep, such as valerian. These products may enhance the medicine’s sedating effects. It is important that healthcare providers be informed about all supplements a patient may be taking.


Q: Does Calmday affect mood or personality in a noticeable way?

A: Regulatory documents list potential psychiatric effects as possible adverse reactions. These include what are known as paradoxical reactions, such as confusion, agitation, irritability, or aggression, which are effects noted in the official safety profile.


Q: Are there any specific laboratory tests required before starting Calmday?

A: The drug is not universally associated with mandatory routine laboratory testing for all patients. However, therapeutic drug monitoring (TDM) or liver and kidney function tests may sometimes be used to assess the drug concentration and ensure proper processing, particularly in patients with pre-existing conditions.


Q: Is Calmday considered a controlled substance?

A: Yes, regulatory authorities classify Nordazepam, the active ingredient in Calmday, as a controlled substance. This classification is based on its pharmacological profile and the potential for physical dependence and misuse.


Q: How is Calmday processed by the body (metabolism)?

A: The official product information describes the drug's active ingredient as being processed primarily through the liver. It undergoes slow metabolism into other substances, which are then further processed (glucuronoconjugation) before the entire compound is excreted from the body, mostly through the urine.


Q: Does the effectiveness of Calmday decrease over time?

A: Official prescribing guidelines and regulatory warnings note that continued use beyond the recommended short duration carries a risk of developing tolerance. Tolerance is a phenomenon where the body adapts to the drug, which can be associated with a loss of the medicine’s initial effectiveness.


Q: What is the significance of the different colors or markings on Calmday pills?

A: The physical characteristics of tablets or capsules, such as their color, shape, or markings, are typically used to distinguish between different dose strengths or to identify the specific manufacturer. Regulatory agencies confirm that generic versions of a brand-name drug may differ in appearance but must contain the same active ingredient.


Q: Can I split or crush Calmday tablets?

A: Official administration instructions specify that tablets or capsules are intended to be swallowed whole and should not be crushed. Splitting or crushing can potentially alter the drug's release pattern in the body, unless a tablet has been specifically manufactured with a score line to allow for accurate division.


How should Calmday be stored and disposed of?

Storage Requirements

Calmday (Nordazepam) must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The regulatory labeling permits temperature excursions up to 30 C (86 F). The product must be kept in its original container, and the container must be tightly closed to protect the medicine from moisture. It is mandatory that Calmday be stored securely and out of the sight and reach of children to prevent accidental ingestion. The product must not be frozen.

Official Disposal Protocol

Unused or expired Calmday should be disposed of through a drug take-back program as the preferred method. If a program is not available, the medicine must be mixed with an unappealing substance, placed in a sealed bag, and disposed of in the household trash. It should not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calmday found in:

A-Z Index: